Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 19 of 29

COMPLETED NA

Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial

NCT02223520
COMPLETED NA

The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism

NCT02200263
COMPLETED Phase 1

A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients

NCT02253264
TERMINATED NA

Miradry Treatment for Focal Axillary Hyperhidrosis

NCT02295891
COMPLETED Phase 2

Environmental Control as Add-on Therapy in Childhood Asthma

NCT02251379
COMPLETED NA

NVAMD Satellite Study

NCT02251366
TERMINATED

Functional Assessment of Coronary Artery Disease by CTA Flow Encoding

NCT02286401
TERMINATED Phase 4

Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz

NCT01980342
COMPLETED NA

tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis

NCT02538094
TERMINATED NA

Remote Ischemic Preconditioning to Prevent Contrast Nephropathy

NCT02674451
COMPLETED NA

MIND: Care Coordination for Community-living Person With Dementia

NCT02396082
COMPLETED NA

Randomized Trial of Rectal Indomethacin and Papillary Spray of Epinephrine Versus Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

NCT02116309
COMPLETED Phase 2

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

NCT02111798
TERMINATED NA

EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors

NCT02282111
TERMINATED Phase 3

Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) Reconstruction

NCT02161705
COMPLETED Phase 4

Pharmacogenomics of Antiplatelet Response

NCT02234427
COMPLETED Phase 1

Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis

NCT02165176
COMPLETED NA

Stylet vs No Stylet During EBUS TBNA

NCT02201654
COMPLETED NA

Bariatric Embolization of Arteries for the Treatment of Obesity

NCT02165124
COMPLETED NA

An Intervention to Reduce Delirium After Cardiac Surgery

NCT02587039
COMPLETED

Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers

NCT03638687
COMPLETED Early Phase 1

Topical Itraconazole in the Treatment of Basal Cell Carcinoma

NCT02120677
COMPLETED NA

Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections

NCT02096653
COMPLETED NA

Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma

NCT02160925
COMPLETED Phase 1

Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

NCT02145091
COMPLETED

Comparison of Femtosecond Laser Assisted Cataract Surgery to Conventional Phacoemulsification Cataract Surgery

NCT02096627
COMPLETED NA

MRI Outcomes of Mindfulness Meditation for Migraine

NCT02133209
COMPLETED NA

Educating Nurses About Venous Thromboembolism (VTE) Prevention

NCT02301793
COMPLETED Phase 2

Prevention of Alcohol Intolerance

NCT01845220
COMPLETED Phase 1

Effects of Hallucinogens and Other Drugs on Mood and Performance

NCT02033707
COMPLETED NA

Using Peer Mentors to Deliver Depression Care

NCT02261818
TERMINATED NA

Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study

NCT02116322
COMPLETED NA

Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke

NCT02039375
COMPLETED

Early Detection of Pancreatic Cystic Neoplasms

NCT02110498
COMPLETED NA

Medial Branch Blocks vs. Intra-articular Injections: Randomized, Controlled Study

NCT02002429
COMPLETED NA

Clinical Trial of Air Cleaners to Improve Indoor Air Quality and COPD Health

NCT02236858
TERMINATED NA

Thalamic Deep Brain Stimulation for the Treatment of Refractory Tourette Syndrome

NCT01817517
COMPLETED NA

The Baltimore HEARS Pilot Study

NCT02045511
COMPLETED NA

Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response

NCT02153359
COMPLETED Phase 2

Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

NCT02166346
COMPLETED

Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests

NCT02252198
TERMINATED NA

The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis

NCT02078375
COMPLETED Early Phase 1

Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects

NCT03070561
COMPLETED Phase 4

Study of the Effectiveness of Ozurdex for the Control of Uveitis

NCT02049476
COMPLETED Phase 4

Stop Community MRSA Colonization Among Patients

NCT02029872
COMPLETED NA

mActive: A Blinded, Randomized mHealth Activity Trial

NCT01917812
COMPLETED NA

Randomized Evaluation of Ten Allergy Skin Prick Test Devices

NCT03509766
COMPLETED Phase 2

Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines

NCT02031679
TERMINATED

The Role of Cerebral Oximetry in Pediatric Concussion Assessment

NCT02036333
TERMINATED NA

Short Forearm Casting Versus Below-elbow Splinting for Acute Immobilization of Distal Radius Fractures

NCT02679066
← Previous Page 19 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

Therapeutic Areas

Hypertension 15
Depression 12
HIV 11
Stroke 10
HIV Infections 8
Mild Cognitive Impairment 7
Dementia 7
Alzheimer Disease 7
Asthma 6
Insomnia 6

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.